The LFA is deeply concerned that the Administration’s proposed changes to Part B may limit patient access to current and future therapies.
Learn about the latest research findings and advancements in lupus science that came out of the world’s premier rheumatology conference.
Mallinckrodt and the LFA Present Data from Survey of Over 1,500 Individuals with Self-Reported Lupus
Study finds individuals with lupus experience a high disease flare burden and as a result engage in preventive and treatment measures.
Doctors Petri and Kahlenberg are names the 2018 recipients of the Evelyn V. Hess Award and Mary Betty Stevens Young Investigator Prize.
LFA Studies Reveal Disparities in Care of Minority Patients and the Role of PCP’s in Care Management
Two studies reveal needs in lupus provider education and care practices for minority patients.
Now accepting donations in the form of cryptocurrency.
Gibson and Manzi to focus on accelerating research toward better treatments and a cure
Lupus experts met with FDA for a Foundation-led delegation to discuss improving clinical trials and health outcomes.